Rights and permissions
About this article
Cite this article
Cost of type 2 DM in The Netherlands `relatively low'. Pharmacoecon. Outcomes News 364, 6 (2002). https://doi.org/10.1007/BF03279112
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279112